🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Semiu O. Gbadamosi

Novo Nordisk (United States)

ORCID: 0000-0003-2048-2943
MedicineHealth ProfessionsImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 6 papers. Top paper: Cardiovascular events, mortality, and incident type 2 diabetes in patients with metabolic dysfunction–associated steatohepatitis: a claims-based analysis of commercial and Medicare Advantage enrollees.

1 citations

Jason P. Swindle, Hai Nguyen, Qian Li, Anthony Hoovler, Semiu O. Gbadamosi

4 citations

Arsalan Hamid, Seth T. Lirette, Semiu O. Gbadamosi, Wondwosen Yimer, Olusola A. Orimoloye +12 more

0 citations

Juliet Iwelunmor, John Olajide Olawepo, Semiu O. Gbadamosi, Alexandra Ezeonu, Adaeze Okoli +6 more

7 citations

Juliet Iwelunmor, John Olajide Olawepo, Semiu O. Gbadamosi, Alexandra Ezeonu, Adaeze Okoli +6 more

N/A
0DataRank · unranked
3 citations

Gregory Boyce, Mary Jo Trepka, Robert J. Edwards, Semiu O. Gbadamosi

2 citations

Stephanie Aleite, Diana M. Sheehan, Tan Li, Semiu O. Gbadamosi, Michèle Jean‐Gilles +3 more